Table 1.
differential diagnosis of biliary hamartoma
| Histological features | Biliary hamartoma | Biliary adenoma | Cholangiocarcinoma | Metastatic adenocarcinomas |
|---|---|---|---|---|
| Biliary structures architecture | Small, dilated tubules; inter anastomosing pattern of growth; open lumens; inspissated bile is common. | Generally small and round tubules; small or inapparent lumens; no inspissated bile. | Generally larger tumors; infiltrating borders and a destructive growth pattern. | Adenocarcinoma with variable appearance (although it is the well differentiated type that may resemble a biliary hamartoma). |
| Cytology | Cytologically bland biliary epithelium: no cytological atypia; no mitotic figures. | Bland cuboidal cells; regular nuclei, resembling ductules. | Cytological atypia mitotic figures, atypical mitosis cellular debris in the lumens of biliary structures (dirty luminal necrosis) strongly favors cholangiocarcinoma. | Cytological atypia; mitotic figures, atypical mitosis; 'garland-like' necrosis in cases of metastatic (colorectal adenocarcinomas). |
| Stroma | Loose and myxoid or densely collagenous; mild lymphocytic inflammation; most hamartomas are located adjacent to, or clearly involve, a portal tract. | Fibrous, shows varying degrees of chronic inflammation and collagenization; portal tracts are often enclosed in the nodule. | Fibrous stroma with marked inflammatory infiltrate; vascular or perineural invasion can be found. | Fibrous stroma with marked inflammatory infiltrate; vascular or perineural invasion can be found. |
| Immunohistochemistry | Express CK7 and CK19; low proliferative rate (Ki-67). | Express CK7 and CK19, and often MUC6, MUC5AC. | CK7, CK19, ACE: usually positive; CK20: positive in 20%; increased proliferation rate on Ki-67; P53: often strong expression. | Segregate according to CK7/CK20 pattern, then apply markers according to the suspected primary site. |